机译:具有抗癌效力的选择性TBK1 / IKKI双抑制剂
Department of Stomatology Xiangya Hospital Central South University Hunan Changsha China;
School of Life Science Central South University Hunan Changsha China;
Department of Cancer Biology Scripps Research Institute Jupiter FL 33458 United States;
Department of Cancer Biology Scripps Research Institute Jupiter FL 33458 United States;
Department of Cancer Biology Scripps Research Institute Jupiter FL 33458 United States;
Department of Stomatology Xiangya Hospital Central South University Hunan Changsha China;
School of Life Science Central South University Hunan Changsha China;
Medicinal Chemistry Translational Research Institute 2A1 Scripps Research Institute Jupiter FL;
Medicinal Chemistry Translational Research Institute 2A1 Scripps Research Institute Jupiter FL;
Department of Cancer Biology Scripps Research Institute Jupiter FL 33458 United States;
cancer; IKKi; TBK1; TBK1/IKKi inhibitor; therapy;
机译:具有抗癌效力的选择性TBK1 / IKKI双抑制剂
机译:患有双阶段抗疟疾效力的新型疟原虫HDAC1抑制剂的发现及基于临床抗癌药物候选Quisinostat的安全性
机译:Amlexanox的羧酸衍生物显示TBK1和IKKε的增强效力,并揭示了选择性抑制的机制
机译:通过暴露于磁场中增强抗癌药的效力
机译:聚(ADP-核糖)聚合酶抑制剂的设计与合成:腺苷袋结合基序附录对3-氧代-2,3-二氢苯并呋喃-7-甲酰胺对效力和选择性的影响
机译:具有抗癌效力的选择性TBK1 / IKKi双重抑制剂
机译:环指蛋白11靶向TBK1 / IKKi激酶以抑制抗病毒信号传导。